"
Team:SupBiotech-Paris/Bibliographie
From 2009.igem.org
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
BioBricks Matériel & Méthode Bibliographie
Ethique & sûreté
Contents |
Thérapies
| Chapitre | Ref. | Auteurs | Titre | Année |
| Thérapie actuelle | [1] | Lechat P. | Pharmacology | 2006 |
| Thérapie actuelle | [2] | Bruguerolle B. | Biological rhythms and medications: a source of variability often neglected in pharmacology | 2008 |
| Thérapie genique | [1] | Kevin J. Scanlon and al. | Cancer Gene Therapy: Challenges and Opportunities | 2004 |
| Thérapie genique | [2] | Gouze JN and al. | A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer | 2003 |
| Thérapie génique | [3] | Centre for Genetics Education | http://www.genetics.com.au/index.asp | XXXX |
Vectorisation
| Chapitre | Ref. | Auteurs | Titre | Année |
| Vectorisation | [1] | Couvreur P. | L'encapsulation de médicament | 2003 |
| Vectorisation | [2] | Andrieux K. and al. | Nanotechnology and new drug | 2003 |
| Vectorisation | [3] | Torchilin V.P. | Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting | 2006 |
| Vectorisation | [4] | Davis M.E. and al. | Nanoparticle therapeutics: an emerging treatment modality for cancer | 2008 |
| Vectorisation | [5] | Seow Y. and al. | Biological Gene Delivery Vehicles: Beyond Viral Vectors | 2009 |
| Vectorisation | [6] | Decroly E. | Vectorology | 2005 |
| Vectorisation | [7] | Robbins P.D. and al. | Viral Vectors for Gene Therapy | 1998 |
| Vectorisation | [8] | Wei M.Q. and al. | Bacterial targeted tumour therapy-dawn of a new era | 2008 |
| Vectorisation | [9] | Ryan R.M. and al. | Use of bacteria in anti-cancer therapies | 2005 |
| Vectorisation | [10] | Mehnert | Solid lipid nanoparticles: Production, characterization and applications | 2001 |
| Vectorisation | [11] | Lasic D.D. | Liposomes in gene therapy | 1996 |
| Vectorisation | [12] | Lutten J. and al. | Biodegradable polymers as non-viral carriers for plasmid DNA delivery | 2008 |
| Vectorisation | [13] | Jiskoot W. and al. | Immunological Risk of Injectable Drug Delivery Systems | 2009 |
| Vectorisation | [14] | Head M. and al. | Mechanism and computer simulation of immune complex formation, opsonization, and clearance | 1996 |
| Vectorisation | [15] | Koide H. and al. | Particle size-dependent triggering of accelerated blood clearance phenomenon | 2008 |
| Vectorisation | [16] | Ishida T. and al. | Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes | 2005 |
| Vectorisation | [17] | Wang XY and al. | Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes | 2007 |
| Vectorisation | [18] | Tosi M.F. and al. | Innate immune responses to infection | 2005 |
| Vectorisation | [19] | Linkov I and al. | Nanotoxicology and nanomedicine: making hard decisions | 2008 |
Vecteur Tissulaire
| Chapitre | Ref. | Auteurs | Titre | Année |
| Vecteur Tissulaire | [1] | Ronald S. and al. | Antimicrobial mechanisms of phagocytes and bacterial evasion strategies | 2009 |
| Vecteur Tissulaire | [2] | Clark B. Inderlied and al. | The Mycobacterium avium Complex | 1993 |
| Vecteur Tissulaire | [3] | Nisheeth Agarwal and al. | Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase | 2009 |
| Vecteur Tissulaire | [4] | Hunter R.L. and al. | Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs | 2007 |
| Vecteur Tissulaire | [5] | Axelrod S and al. | Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide | 2008 |
| Vecteur Tissulaire | [6] | Nicole N van der Wel and al. | Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy | 2005 |
| Vecteur Tissulaire | [7] | Claudia Nobrega and al. | The thymus as a target for mycobacterial infections | 2007 |
Vecteur Cellulaire
| Chapitre | Ref. | Auteurs | Titre | Année |
| Vecteur Cellulaire | [1] | Harrison Echols and al. | Genetic Map of Bacteriophage Lambda | 1978 |
| Vecteur Cellulaire | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Vecteur Cellulaire | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Vecteur Cellulaire | [4] | Ortega ME and al. | Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor | 2006 |
| Vecteur Cellulaire | [5] | Feiss M. and al. | Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging | 2005 |
| Vecteur Cellulaire | [6] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Vecteur Cellulaire | [7] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Vecteur Cellulaire | [8] | Hochschild A and al. | The bactériophage lambda cI protein finds an asymmetric solution | 2009 |
| Vecteur Cellulaire | [9] | Phoebe L.Stewart1 and al. | Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization | 1997 |
Plasmide Thérapeutique
| Chapitre | Ref. | Auteurs | Titre | Année |
| Plasmide thérapeutique | [1] | Ortega ME et al. | Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor | 2006 |
| Plasmide thérapeutique | [2] | Joseph Sambrook and al. | Molecular Cloning: A Laboratory Manual (Third Edition) | 2001 |
| Plasmide thérapeutique | [3] | Court DL and al. | A New Look at Bacteriophage lambda Genetic Networks | 2007 |
| Plasmide thérapeutique | [4] | Feiss M. and al. | Viral Genome Packaging Machines: Genetics, Structure and Mechanism | 2005 |
| Plasmide thérapeutique | [5] | Hang JQ and al. | The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB | 2001 |
| Plasmide thérapeutique | [6] | Becker A and al. | Bacteriophage lambda DNA : The begginning of the End | 1990 |
| Plasmide thérapeutique | [7] | Young et al. | Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature | 2003 |
Action antitumorale
| Chapitre | Ref. | Auteurs | Titre | Année |
| Action antitumorale | [1] | Chunlin Yang et al | Adenovirus-mediated Wild-Type p53 Expression Induces Apoptosis and Suppresses Tumorigenesis of Prostatic Tumor Cells | 1995 |
| Action antitumorale | [2] | Corrado Cirielli et al. | Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma | 1999 |
| Action antitumorale | [3] | Su-Ping Ren et al. | Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro | 2006 |
| Action antitumorale | [4] | Zhao-hua Qiu et al | Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes | 2002 |
| Action antitumorale | [5] | Zhao-hua Qiu et al. | Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells | 2001 |
| Action antitumorale | [6] | Markus Reiser et al. | Induction of cell proliferation arrest and apoptosis in hepatoma cells through adenoviral-mediated transfer of p53 gene | 2000 |
| Action antitumorale | [7] | Louis L. Pisters et al. | Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer | 2004 |
| Action antitumorale | [8] | Susan C. Modesitt et al. | In Vitro and in Vivo Adenovirus-mediated p53 and p16 Tumor Suppressor Therapy in Ovarian Cancer | 2001 |
| Action antitumorale | [9] | Yong-song GUAN et al. | Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up | 2009 |
Ethique
| Chapter | Ref. | Authors | Title | Year |
| Ethique | [1] | Joël Rosnay | Biologie de synthèse: Enjeux et défis pour l’humanité | 2004 |
| Ethique | [2] | Synbiosafe | http://www.synbiosafe.eu/forum/ | 2008 |
| Ethique | [3] | Bernadette Bensaude Vincent, Dorothée Benoit-Browaeys | Petite typologie de la biologie synthétique et enjeux éthiques | 2009 |
| Ethique | [4] | Anna Deplazes Æ Markus Huppenbauer | Synthetic organisms and living machines | 2004 |
| Ethique | [5] | Schmidt M, Ganguli-Mitra A,and al. | A priority paper for the societal and ethical aspects of synthetic biology | 2009 |
| Ethique | [6] | Parens E, Johnston J, Moses J. | Ethics. Do we need "synthetic bioethics"? | 2009 |
Sûreté
| Chapitre | Ref. | Auteurs | Titre | Année |
| Sûreté | [1] | Jonathan B. Tucker and al. | The Promise and Perils of Synthetic Biology | 2006 |
| Sûreté | [2] | Synbiosafe | http://www.synbiosafe.eu/forum/ | 2008 |
| Sûreté | [3] | Vivagora | http://www.vivagora.org/IMG/pdf/CR-biosynth011009.pdf | 2009 |
| Sûreté | [4] | New Atlantis | http://www.thenewatlantis.com/publications/life-from-scratch | 2004 |
